Genetically engineered antibodies in gene transfer and gene therapy

Human Gene Therapy

Volumn 9, Issue 15, 1998, Pages 2165-2175

  Pelegrin, Mireia ^a   Marin, Mariana ^a   Noël, Danièle ^a   Piechaczyk, Marc ^a,b  

^a CNRS   (France)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; VIRUS VECTOR;

ADENOVIRUS; CANCER; EFFECTOR CELL; GENE TARGETING; GENE THERAPY; GENE TRANSFER; IMMUNOTHERAPY; REVIEW; VIRUS INFECTION; VIRUS INHIBITION;

ADENOVIRIDAE;

EID: 0032505742     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.15-2165     Document Type: Review

References (12)

1. ABKEN, H., HOMBACH, A., REINHOLD, U., and FERRONE, S. (1998). Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells? Trends Immunol. 19, 2-5.
2. AGER, S., NILSON, B.H.K., MORLING, F.J., PENG, K.W., COSSET, F.L., and RUSSELL, S. (1996). Retroviral display of antibody fragments; Interdomain spacing strongly influences vector infectivity. Hum. Gene Ther. 7, 2157-2164.
3. ANDERSON, W. (1992). Human gene therapy. Science 256, 808-813.
4. BALTIMORE, D. (1988). Intracellular immunization. Nature (London) 335, 395-396.
5. BEERLY, R.R., WELS, W., and HYNES, N.E. (1994). Intracellular expression of single chain antibodies reverts ErbB-2 transformation. J. Biol. Chem. 269, 23931-23936.
6. BIOCCA, S., PIERANDREI-AMALDI, P., and CATTANEO, A. (1993). Intracellular expression of anti-p21ras single chain Fv frag-ments inhibits meiotic maturation of Xenopus oocytes. Biochem. Biophys. Res. Commun. 197, 422-427.
7. BIOCCA, S., PIERANDREI-AMALDI, P., CAMPIONI, N., and CATTANEO, A. (1994). Intracellular immunization with cytosolic recombinant antibodies. BioTechnology 12, 396-399.
8. BRUGGEMANN, M., and TAUSSIG, M.J. (1997). Production of human antibody repertoires in transgenic mice. Curr. Opin. Biotechnol. 8, 455-458.
9. BUONOCORE, L., and ROSE, J.K. (1993). Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat. Proc. Natl. Acad. Sci. U.S.A. 90, 2695-2699.
10. BURTON, D.R. (1997). A vaccine for HIV type 1: The antibody perspective. Proc. Natl. Acad. Sci. U.S.A. 94, 10018-10023.
11. CHU, T.-H., and DORNBURG, R. (1995). Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J. Virol. 69, 2659-2663.
12. CHU, T.-H., and DORNBURG, R. (1997). Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies. J. Virol. 71, 720-725.